Ajit Singh wants airfare made public

Aviation analyst says it is difficult to get airlines to do this because it will reveal their business model

srishti

Srishti Pandey | March 14, 2013



Hitting back at airlines for refusing to divulge details of airfares and availability of seats in each fare slab civil aviation minister Ajit Singh has said that the companies cannot refuse to provide information as it is in the larger public interest.

Putting to rest the concerns of the airline companies that the move would result in regulation of airfares, the minister assured that the government did not intend to regulate fares even if it came across companies indulging in anti-competitive or predatory pricing. Instead, in such a situation the matter would be referred to the Competition Commission of India.

On January 23, the supreme court had directed airlines to furnish details regarding the number of seats available at each fare level but a final order has not been passed.

Meanwhile, experts have expressed their concerns on the move being implemented.

Speaking to Governance Now Sharan Lillaney, aviation analyst at Angel Broking said, “It is very difficult to get airlines to do this because it will reveal their business model and will increase the risk of rivals copying or misusing it.”

About the chances of the move being implemented, Lillaney said, “It does not seem very likely as the government, in the past, has said a lot of things but not everything has been implemented. Also, it does not make any sense for the government to worry about cartelisation in this sector as it is a loss-making sector.”

Echoing the sentiment, Rajiv Chib, associate director, PricewaterhouseCoopers said that airlines companies should be allowed a certain amount of privacy when it comes to deciding airfares. “That much privacy should be allowed and it would be more ethical to not force the move upon these companies.”

On being asked if the move would impact the attractiveness of the bleeding sector in the country, he replied, “It will not harm the prospects of foreign investment in the sector but this kind of regulatory interference is not desirable as it challenges the basic premise of liberalising the sector.”  

Comments

 

Other News

Strong El Nino threat over India`s monsoon, food & water security

India is heading into the southwest monsoon season this year under the shadow of a rapidly strengthening El Nino, with meteorologists warning that the climate phenomenon could significantly disrupt rainfall patterns, intensify heat stress and place additional pressure on the country’s agriculture-d

How corporates can nudge real change

The Business Of Business Is (Not) Just Business: How Behavioural Tools Can Drive Real Change Edited by Sutapa Banerjee, with Foreword by Nadir Godrej HarperCollins, 336 pages, Rs 699  

India stopped jailing people for paperwork. Now comes the hard part

A small pharmacist in Rajkot neglects to change a notice in his store under a little-known clause of a public health law. This was not only a non-compliance matter, but also a criminal offence, and a jail sentence was the punishment under the old system. Not a fine. Not a warning. Jail. Now scale

How to make our cities climate-resilient

Indian cities are growing at a pace that our infrastructure and climate can no longer sustain. This rapid urban sprawl increasingly strains urban systems, overshadowing the severe environmental fallout produced in its wake. The repercussions include Urban Heat Island Effect (UHI), Urban Floods, and many mo

Trump’s China setback pushes US to woo India

A week after Donald Trump’s visit to China – the first by an American president in nine years, US secretary of state Marco Rubio arrived in India on May 23 on a four-day visit aimed at resetting Washington DC’s relations with New Delhi and attending the third Quad ministerial meeting.

EU–India FTA 2026: A high‑stakes prescription for Indian pharma and healthcare

India’s pharmaceutical industry stands as one of the world’s market leaders of generic pharmacy with market valuation of USD 50 billion in 2026. Characterised by high volume, low-cost generic manufacturing, with an annual growth rate of 10-12% primarily propelled by exports and domestic demand,





Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter